Global Antiviral Drug Resistance Market to 2027
www.theinsightpartners.com
ANTIVIRAL DRUG RESISTANCE MARKET To 2027 Global Analysis and Forecasts By Product (Kits & Reagents and Instruments), Disease Indication (Human Immunodeficiency Virus [HIV], Hepatitis and Cytomegalovirus [CMV]), Technology (Immunodiagnostics, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS], and Other Technologies), End User (Hospitals & Clinics, Pathology or Diagnostic Laboratories and Research Institutes), and Geography
1
Global Antiviral Drug Resistance Market to 2027
www.theinsightpartners.com
The global antiviral drug resistance market expected to be US$ 2,572.26 Mn in 2018 and is predicted to grow at a CAGR of 6.8% during the forecast period 2019 - 2027, to reach US$ 4,573.24 Mn by 2027. Europe is the second largest geographic market and is expected to be the second most significant revenue contributor throughout the forecast period. The region has witnessed several advancements in the field of biotechnology due to increased emphasis on R&D activities in the region. The growth is driven by factors such as increased prevalence of HIV and hepatitis and supportive policies by the government to tackle burden of the diseases. Market Insights Rise in the Incidences of Hepatitis Diseases Viruses are the tinier germs that can cause several infectious diseases such as flu, common cold, and warts. Viruses can also cause severe illnesses, including smallpox, HIV/AIDS, and Ebola. Viruses reproduce inside cells and able to enter into any living, healthy cells and multiply and produce other viruses like themselves. Different viruses attack specific cells in the body such as liver, brain, skin, blood and also reproductive, respiratory, and gastrointestinal systems. The prevalence of virus infections such as hepatitis has increased during recent years across the globe. Hepatitis causes liver damage and inflammation that can also damage other organs. It is a major global health problem that can cause chronic infection and also upsurge the higher risk of death from cirrhosis and liver cancer. Hepatitis can be categorized as hepatitis A, B, C, D, and E that spread through different causes. According to the WHO (World Health Organization), the prevalence of Hepatitis B is the highest in the African and Western Pacific Region, where 6.1% and 6.2% of the adult population is infected respectively. Increasing Healthcare Expenditures in Emerging Markets The increasing healthcare expenditure in the emerging economies such as Asia Pacific and South and Central America are enabling the researchers to develop treatment options for a wide range of viral diseases by utilizing advanced techniques such as PCR (Polymerase Chain
2
Global Antiviral Drug Resistance Market to 2027
www.theinsightpartners.com
Reaction), next generation sequencing and others. The viral infectious diseases is anticipated to remain a major public health problem in the coming decades, which poses a threat to both national and international health security. Endemic diseases including, human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) will continue to challenge public health. For the early detection and rapid response, high level of awareness is required across the region. Thus, the rapid growth and innovations coming from the emerging nations are expected to increasing the growth opportunities and sales in the global antiviral drug resistance market. Product Insights The global antiviral drug resistance market by product was led by kits and reagents segment. In 2018, the segment of held the largest market share in the antiviral drug resistance market, by product. The segment is also expected to witness growth at a significant rate during the forecast period since they are an essential requirement for conducting various tests. ANTIVIRAL DRUG RESISTANCE – MARKET SEGMENTATION By Product
Kits and Reagents
Instruments
By Disease Indication
Human Immunodeficiency Virus (HIV)
Hepatitis
Cytomegalovirus (CMV)
By Disease Technologies
Immunodiagnostics
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Other Technologies
3
Global Antiviral Drug Resistance Market to 2027
www.theinsightpartners.com
By End User
Hospitals & Clinics
Pathology or Diagnostic Laboratories
Research Institutes
By Geography
North America o
U.S.
o
Canada
o
Mexico
Europe o
France
o
Germany
o
UK
o
Spain
o
Italy
Asia Pacific (APAC) o
China
o
India
o
Japan
o
Australia
o
South Korea
Middle East & Africa (MEA) o
Saudi Arabia
o
South Africa
o
UAE
South and Central America o
Brazil
o
Argentina
Check Sample Report at https://www.theinsightpartners.com/sample/TIPRE00006395
4
Global Antiviral Drug Resistance Market to 2027
www.theinsightpartners.com
ABOUT US The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Technology, Media, and Telecommunication. Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis. Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, technology, products, and services etc., which helps our clients to gain a deeper analytical understanding of various research topics.
CONTACT US If you have any queries about this report or would like further information, please contact us: North America:
+1 646 491 9876
Email:
sales@theinsightpartners.com
DISCLAIMER All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, “The Insight Partners”. The facts of this report are believed to be correct at the time of publication but cannot be guaranteed. Please note that the findings, conclusions, and recommendations that “The Insight Partners” delivers will be based on information gathered in good faith from primary and secondary sources, whose accuracy we are not always in a position to guarantee.
5
Global Antiviral Drug Resistance Market to 2027
www.theinsightpartners.com
As such, “The Insight Partners� can accept no liability whatsoever for actions taken based on any information that may subsequently prove to be incorrect.
6